🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Consolidation

Blinatumomab Consolidation in Real World NCT07117136n/a5 sites📍 Jacksonville📍 Chicago📍 Chicago Medical College of Wisconsin Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT NCT05623267Phase 2, Phase 31 site📍 Guangzhou Sun Yat-sen University · Tests: Sugemalimab, Placebo A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia NCT07400029Phase 29 sites📍 Duarte📍 Stanford📍 Basking Ridge Memorial Sloan Kettering Cancer Center · Tests: Obecabtagene Autoleucel Study of Tislelizumab for Locally Advanced Non-Small Cell Lung Cancer Following Neoadjuvant Chemotherapy Plus Tislelizumab ± Bevacizumab and Definitive Concurrent Chemoradiation Therapy NCT05468242Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Neoadjuvant chemo-immunotherapy, Bevacizumab, Radiotherapy, Tislelizumab Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE) NCT06993675Phase 22 sites📍 New Haven📍 Rochester Noffar Bar · Tests: Talquetamab, Teclistamab Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV) NCT07509151Phase 344 sites📍 La Jolla📍 Denver📍 New Haven AstraZeneca · Tests: Surovatamig Chemoradiation and Consolidation Chemotherapy With or Without Oxaliplatin for Distal Rectal Cancer and Watch and Wait NCT05000697NA24 sites📍 Buenos Aires📍 Buenos Aires📍 Buenos Aires Hospital Alemão Oswaldo Cruz · Tests: Oxaliplatin, 5FU Axicabtagene Ciloleucel for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma NCT06609304Phase 41 site📍 Zhengzhou Zhengzhou University · Tests: Axicabtagene Ciloleucel IMMUNOPLANT for Newly Diagnosed Multiple Myeloma NCT06376526Phase 21 site📍 Miami Dickran Kazandjian, MD · Tests: Linvoseltamab Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma NCT04561206Phase 25 sites📍 Duarte📍 Chicago📍 Boston City of Hope Medical Center · Tests: Brentuximab Vedotin, Nivolumab Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab NCT06287229Phase 1, Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Blinatumomab, Inotuzumab Ozogamicin, Hyper-CVAD, Mini-hyper-CVD A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy NCT07010263Phase 353 sites📍 Beijing📍 Beijing📍 Beijing Akeso · Tests: AK112, Placebo Efficacy of Integrated Induction-Consolidation Chemotherapy and Transplantation for Adult Acute Myeloid Leukemia: Multicenter Study NCT07108530Phase 21 site📍 Taiyuan Shanxi Bethune Hospital · Tests: Integrated IAV/MA Chemotherapy and Allo-HSCT Protocol for Adult AML, First Induction (IAV or DAV Regimen), Consolidatio… Estradiol and Intrusive Memories NCT07419594NA1 site📍 Berlin Charite University, Berlin, Germany · Tests: Estradiol Valerate, Placebo Lorlatinib Plus Local Consolidation Therapy In ALK Positive Advanced Non-Small Cell Lung Cancer NCT07415005Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Lorlatinib Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR NCT02416388Phase 2, Phase 356 sites📍 Amiens📍 Angers📍 Argenteuil University Hospital, Angers · Tests: Idarubicin, Daunorubicin, HD Cytarabine, Cyclosporine, Methotrexate Induction Chemoimmunotherapy in Combination With Chemoradiotherapy and Consolidation Immunotherapy in Unresectable Locally Advanced Non-Small Cell Lung Cancer NCT07632365Phase 1, Phase 21 site📍 Shanghai Shanghai Chest Hospital · Tests: Induction chemoimmunotherapy, Concurrent chemoradiotherapy (cCRT), consolidation immunotherapy CAR-T Cell Therapy, Mosunetuzumab and Polatuzumab for Treatment of Refractory/Relapsed Aggressive Non-Hodgkin's Lymphoma (NHL). NCT05260957Phase 21 site📍 Miami Lazaros Lekakis · Tests: Mosunetuzumab, Polatuzumab, CAR-T Cell Therapy Elranatamab in R/R Multiple Myeloma NCT06138275Phase 23 sites📍 Boston📍 Boston📍 Boston Massachusetts General Hospital · Tests: Elranatamab tDCS: Sleep to Mood in Depression (S2M-D) NCT07572526NA1 site📍 New York NYU Langone Health · Tests: transcranial direct current stimulation (tDCS) Chemoradiation Plus Iparomlimab Consolidation in Older With ESCC NCT07038629Phase 21 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: S1, Iparomlimab, Radiation Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma NCT05366829Phase 22 sites📍 New Brunswick📍 The Bronx Rutgers, The State University of New Jersey · Tests: Tislelizumab Durvalumab as Consolidation for Patients LS-SCLC NCT07055581Phase 22 sites📍 Zhengzhou📍 Wuhan Qian Chu · Tests: Induction Durvalumab +etoposide/platinum +Radiochemotherapy+ durvalumab maintenance VA Consolidation in Intermediate-Risk AML NCT07672262Phase 21 site📍 Suzhou The First Affiliated Hospital of Soochow University · Tests: Venetoclax and Azacitidine, Cytarabine ± Anthracycline Unravelling The Optimisation And Consolidation Of Motor Skills In People With Multiple Sclerosis With Mild to Moderate Gait Impairment: A Feasibility Study NCT07058870NA1 site📍 Ferrara University Hospital of Ferrara · Tests: High Intensity Task Oriented Circuit Training + Telerehabilitation A Study to Compare Early and Partial Weight-bearing After Hallux Valgus Surgery NCT05534724NA1 site📍 Lugano Ente Ospedaliero Cantonale, Bellinzona · Tests: Partial weight-bearing (10 - 15kg), Complete weight-bearing Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation NCT06942039EARLY Phase 112 sites📍 Calgary📍 Vancouver📍 Winnipeg C17 Council · Tests: Cytarabine IT, hydrocortisone, Cisplatin, Vincristine, Etoposide Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM Patients NCT06918002Phase 369 sites📍 Brussels📍 Brussels📍 Charleroi Intergroupe Francophone du Myelome · Tests: Elranatamab, Lenalidomide (Revlimid®), Daratumumab SC (Darzalex), Autologous Stem Cell Transplantation, Bortezomib (Vel… Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia NCT03214562Phase 1, Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Cytarabine, Filgrastim, Fludarabine, Idarubicin, Pegfilgrastim CD19/CD22 CAR-T as First-line Consolidation in Follicular Lymphoma NCT07587840Phase 21 site📍 Beijing Liping Dou · Tests: CD22/CD19 CAR-T cell immunotherapy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy